I didn’t even know there was a sublingual pot spray for MS. And now I can’t use it. Damn.
LONDON (Reuters) – There is little evidence to back the use of a cannabis extract spray made by GW Pharmaceuticals for spasticity in patients with multiple sclerosis, according to a… report in the Drug and Therapeutics Bulletin (DTB).
Sativex is sold as a prescription drug in Britain by GW’s partner, German group Bayer.
Well, it’s for spasticity, so I couldn’t use it anyway. If I hadn’t fixed that frozen shoulder I might have passed that off as spasticity.
GW Pharma said the article contradicted the opinion of 22 separate national authorities in Europe and around the world that have granted approval for Sativex. … The drug is currently sold in Britain, Germany, Spain, Denmark, Norway, Canada and Israel.
Can you imagine? Pot, but you don’t have to smoke it or ruin a good batch of brownies.